[Necrotizing Soft Tissue Infection Caused by Serratia marcescens in a Patient Treated with Tocilizumab]

Kansenshogaku Zasshi. 2015 Jan;89(1):53-5. doi: 10.11150/kansenshogakuzasshi.89.53.
[Article in Japanese]

Abstract

We report herein on a case of community-acquired necrotizing soft tissue infection caused by Serratia marcescens. The patient had been treated with prednisolone, tocilizumab and tacrolimus for rheumatoid arthritis. Since Gram staining of the tissue revealed Gram negative rod bacteria, ceftriaxone and clindamycin were administered as empiric therapy. Tissue culture revealed S. marcescens. Ceftriaxone was continued according to the antibiotic sensitivity. She underwent debridement of necrotic tissue and continued ceftriaxone for 17 days. She recovered and was discharged after skin grafting.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Ceftriaxone / therapeutic use*
  • Clindamycin / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Serratia marcescens*
  • Soft Tissue Infections / diagnosis
  • Soft Tissue Infections / drug therapy*
  • Soft Tissue Infections / microbiology*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Ceftriaxone